摘要
肝硬化患者常出现各类血细胞减少,其中血小板减少尤为常见.此类患者血小板减少的原因常归咎于血小板在肿大的脾脏中淤积和破坏,即脾功能亢进.
出处
《胃肠病学》
2003年第1期53-54,56,共3页
Chinese Journal of Gastroenterology
参考文献18
-
1[1]Kelemen E, Cserhati I, Tanos B. Demonstration and some properties of human thrombopoietin in thrombocythaemic sera. Acta Haematol, 1958, 20:350～ 355.
-
2[2]Wendling F, Varlet P, Charon M, Tambourin P.MPLV: a retrovirus complex inducing an acute myeloproliferative leukemic disorder in adult mice. Virology, 1986, 149: 242～246.
-
3[3]Methia N, Louache F, Vainchenker W, Wendling F. Oligodeoxynucleotides antisense to the protooncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood, 1993, 82: 1395～1401.
-
4[4]de Sauvage FJ, Hass PE, Spencer SD, Malloy BE,Gurney AL, Spencer SA, Darbonne WC, Henzel WJ, Wong SC, Kuang WJ, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature, 1994, 369: 533～538.
-
5[5]Qian S, Fu F, Li W, Chen Q, de Sauvage FJ. Primary role of the liver in thrombopoietin production shown by tissue-specific knockout. Blood, 1998,92: 2189～2191.
-
6[6]Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood, 1997, 89:101～107.
-
7[7]Jelkmann W. The role of the liver in the production of thrombopoietin compared with erythropoietin. Eur J Gastroenterol Hepatol, 2001, 13:791 ～801.
-
8[9]Broudy VC, Lin NL, Kaushansky K. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro. Blood, 1995, 85: 1719～1726.
-
9[10]Ulich TR, del Castillo J, Senaldi G, Cheung E,Roskos L, Young J, Molineux G, Guo J, Schoemperlen J, Munyakazi L, Murphy-Filkins R, Tarpley JE, Toombs CF, Kaufman S, Yin S, Nelson AG, Nichol JL, Sheridan WP. The prolonged hematologic effects of a single injection of PEGrHuMGDF in normal and thrombocytopenic mice.Exp Hematol, 1999, 27: 117～130.
-
10[11]Farese AM, Hunt P, Boone T, MacVittie TJ. Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood, 1995, 86:54～59.
同被引文献3
-
1病毒性肝炎防治方案（试行）[J].中华传染病杂志,1995,13(4):241-247. 被引量：1767
-
2周建方,项爱英,施柏年,张国雷.门腔分流术对肝硬化脾功能亢进患者血小板参数的影响[J].肝脏,2000,5(1):58-58. 被引量：1
-
3郝建宇,夏成青,周华三.肝硬化患者血小板活化状态的变化[J].中华内科杂志,2003,42(3):203-203. 被引量：3
-
1金蓉珍,罗鸣,朱彦,张鹤云,王石泉,张太平,黄诒森.国产血小板生成素治疗再生障碍性贫血疗效观察[J].镇江医学院学报,1996,6(2):118-118.
-
2张春燕,易文生,王玲珑,丁育松,余月华,屠丽萍.肝纤维化进程中病人血清EPO、TPO、GM-CSF的变化[J].中华放射医学与防护杂志,2004,24(4):360-361.
-
3刘鹏亮,孙杰生,王炳元,秦永军.肝硬化患者Child-Pugh分级与血小板生成素的关系[J].世界华人消化杂志,2010,18(4):392-396. 被引量：18
-
4宣言,刘建民.维生素D在2型糖尿病发生发展中的作用[J].诊断学理论与实践,2012,11(1):88-90. 被引量：4
-
5爱吃米饭罹患糖尿病风险高[J].基础医学与临床,2013,33(4):428-428.
-
6陆晔,潘湘涛,王金湖,程旭,李蓉,严敏.不同原因血小板减少症TPO检测及意义[J].中国医疗前沿,2009,4(17):23-23. 被引量：1
-
7龙玉,唐卉.甲状腺过氧化物酶抗体对妊娠结局及后代智力影响的研究进展[J].蛇志,2013,25(2):219-221. 被引量：2
-
8陆亚岚,高清平.ITP患者促血小板生成素与T淋巴细胞亚群的相关性分析[J].医学临床研究,2013,30(10):2014-2016. 被引量：2
-
9芮志莲,吴家明.肝病患者血清血小板生成素水平与血小板计数关系的初步探讨[J].放射免疫学杂志,2005,18(6):512-513. 被引量：1
-
10丁红芳,高欣义,杨昭华,王连英,刘杰.血小板生成素和转化生长因子-β_1在儿童血液病中的研究[J].中国小儿血液,2005,10(6):255-257. 被引量：3
